It looks like it has a huge amount of potential. As they prove this find they feel they will get taken out.

They continue to build the company. They are merging with Weed MD to get into the medical side. They are building up the cultivations side as well as the branding side. He thinks it could be a lot bigger company the way they are executing.

It pulled back recently and he thinks there is more light shed on the recent transactions they were a part of. It has bottomed and is moving up.

It is interesting in the way they have transitioned their business to cultivation. It is on his radar. It has some possibilities down the road.

You have seen the price of gold starting to stabilize and then a number of gold companies have started to outperform, on a technical basis, the price of gold.

It has been a bumpy ride recently. It is probably a good entry point. Recently there was bad press about unhappy franchisees. Longer term they continue to innovate and come up with new products. He thinks they will continue to make acquisitions as well.

They are significantly cheaper than the bigger peers in Canada, yet will have production the same size when they are built. They have lower wage rates than others so their production costs are lower. They have a multiyear agreement with the Quebec Cannabis authority so they have a supply arrangement in place. They have already gone into other product areas. (Analysts’ target: $7.42).